A citation-based method for searching scientific literature

Aline Rangel-Pozzo, Luiza Sisdelli, Maria Isabel V Cordioli, Fernanda Vaisman, Paola Caria, Sabine Mai, Janete M Cerutti. Cancers (Basel) 2020
Times Cited: 8







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
37

Genomic Characterization of Differentiated Thyroid Carcinoma.
Young Shin Song, Young Joo Park. Endocrinol Metab (Seoul) 2019
18
37

The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Ling Zhao, Lin Wang, Xiaomeng Jia, Xiaodong Hu, Ping Pang, Sitong Zhao, Yajing Wang, Jing Wang, Yingshi Zhang, Zhaohui Lyu. Front Oncol 2020
5
40

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Seong-Keun Yoo, Seungbok Lee, Su-Jin Kim, Hyeon-Gun Jee, Byoung-Ae Kim, Hyesun Cho, Young Shin Song, Sun Wook Cho, Jae-Kyung Won, Jong-Yeon Shin,[...]. PLoS Genet 2016
152
25

Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.
Jinwei Hu, Isabella J Yuan, Saied Mirshahidi, Alfred Simental, Steve C Lee, Xiangpeng Yuan. Int J Mol Sci 2021
4
50

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Yuri E Nikiforov, Raja R Seethala, Giovanni Tallini, Zubair W Baloch, Fulvio Basolo, Lester D R Thompson, Justine A Barletta, Bruce M Wenig, Abir Al Ghuzlan, Kennichi Kakudo,[...]. JAMA Oncol 2016
752
25



Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.
Elena Tirrò, Federica Martorana, Chiara Romano, Silvia Rita Vitale, Gianmarco Motta, Sandra Di Gregorio, Michele Massimino, Maria Stella Pennisi, Stefania Stella, Adriana Puma,[...]. Genes (Basel) 2019
33
25

Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario.
Francesca Galuppini, Federica Vianello, Simona Censi, Susi Barollo, Loris Bertazza, Sofia Carducci, Chiara Colato, Jacopo Manso, Massimo Rugge, Maurizio Iacobone,[...]. Front Endocrinol (Lausanne) 2019
14
25

Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015).
Ian D Hay, Tammi R Johnson, Suneetha Kaggal, Megan S Reinalda, Nicole M Iniguez-Ariza, Clive S Grant, Siobhan T Pittock, Geoffrey B Thompson. World J Surg 2018
43
25

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
Gary L Francis, Steven G Waguespack, Andrew J Bauer, Peter Angelos, Salvatore Benvenga, Janete M Cerutti, Catherine A Dinauer, Jill Hamilton, Ian D Hay, Markus Luster,[...]. Thyroid 2015
448
25

Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.
Andrew J Bauer. Endocrinol Metab Clin North Am 2020
5
40


Telomere shortening in patients with plasma cell disorders.
Alejandra Cottliar, Estela Pedrazzini, Claudia Corrado, María Inés Engelberger, Marina Narbaitz, Irma Slavutsky. Eur J Haematol 2003
28
12



Distinct Nuclear Organization of Telomeresand Centromeres in Monoclonal Gammopathyof Undetermined Significance and Multiple Myeloma.
Pak Lok Ivan Yu, Yaqiong Wang, Pille Tammur, Anu Tamm, Mari Punab, Aline Rangel-Pozzo, Sabine Mai. Cells 2019
2
50

Drug Targeting of Genomic Instability in Multiple Myeloma.
Meral Beksac, Sevinc Balli, Dilara Akcora Yildiz. Front Genet 2020
6
16

Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients.
Darrel Drachenberg, Julius A Awe, Aline Rangel Pozzo, Jeff Saranchuk, Sabine Mai. Cancers (Basel) 2019
6
16


Genomic Instability in Circulating Tumor Cells.
Monique Oliveira Freitas, John Gartner, Aline Rangel-Pozzo, Sabine Mai. Cancers (Basel) 2020
2
50

Three-dimensional Nuclear Telomere Organization in Multiple Myeloma.
Ludger Klewes, Rhea Vallente, Eric Dupas, Carolin Brand, Dietrich Grün, Amanda Guffei, Chirawadee Sathitruangsak, Julius A Awe, Alexandra Kuzyk, Daniel Lichtensztejn,[...]. Transl Oncol 2013
14
12

Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.
Antonia Cagnetta, Davide Lovera, Raffaella Grasso, Nicoletta Colombo, Letizia Canepa, Filippo Ballerini, Marino Calvio, Maurizio Miglino, Marco Gobbi, Roberto Lemoli,[...]. Biomed Res Int 2015
12
12

Genomic Instability in Multiple Myeloma.
David A Alagpulinsa, Raphael E Szalat, Mark C Poznansky, Robert J Shmookler Reis. Trends Cancer 2020
6
16

Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
Kai-Da Wu, Lisa M Orme, John Shaughnessy, Joth Jacobson, Bart Barlogie, Malcolm A S Moore. Blood 2003
81
12

Characterizing the three-dimensional organization of telomeres.
B J Vermolen, Y Garini, S Mai, V Mougey, T Fest, T C-Y Chuang, A Y-C Chuang, L Wark, I T Young. Cytometry A 2005
79
12

ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies.
Oronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, Michela Frenquelli, Daniela Belloni, Lucia Bongiovanni, Stefania Girlanda, Simona Di Terlizzi, Marina Ferrarini, Elisabetta Ferrero,[...]. Haematologica 2019
4
25

Genomic patterns of progression in smoldering multiple myeloma.
Niccolò Bolli, Francesco Maura, Stephane Minvielle, Dominik Gloznik, Raphael Szalat, Anthony Fullam, Inigo Martincorena, Kevin J Dawson, Mehmet Kemal Samur, Jorge Zamora,[...]. Nat Commun 2018
94
12


State of the science in smoldering myeloma: Should we be treating in the clinic?
Elizabeth Hill, Alex Dew, Dickran Kazandjian. Semin Oncol 2019
7
14

ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies.
Oronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, Michela Frenquelli, Daniela Belloni, Lucia Bongiovanni, Stefania Girlanda, Simona Di Terlizzi, Marina Ferrarini, Elisabetta Ferrero,[...]. Haematologica 2020
3
33

From cellular morphology to molecular and epigenetic anomalies of myelodysplastic syndromes.
Macoura Gadji, Aline Rangel Pozzo. Genes Chromosomes Cancer 2019
4
25

Telomere length is a critical determinant for survival in multiple myeloma.
Sam Hyatt, Rhiannon E Jones, Nicole H Heppel, Julia W Grimstead, Chris Fegan, Graham H Jackson, Robert Hills, James M Allan, Guy Pratt, Chris Pepper,[...]. Br J Haematol 2017
22
12

Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.
Robert A Kyle, Ellen D Remstein, Terry M Therneau, Angela Dispenzieri, Paul J Kurtin, Janice M Hodnefield, Dirk R Larson, Matthew F Plevak, Diane F Jelinek, Rafael Fonseca,[...]. N Engl J Med 2007
487
12


International staging system for multiple myeloma.
Philip R Greipp, Jesus San Miguel, Brian G M Durie, John J Crowley, Bart Barlogie, Joan Bladé, Mario Boccadoro, J Anthony Child, Herve Avet-Loiseau, Robert A Kyle,[...]. J Clin Oncol 2005
12

Telomere dysfunction and its role in haematological cancer.
Ceri H Jones, Chris Pepper, Duncan M Baird. Br J Haematol 2012
37
12

3D Telomere Structure Analysis to DetectGenomic Instability and Cytogenetic Evolutionin Myelodysplastic Syndromes.
Aline Rangel-Pozzo, Daiane Corrêa de Souza, Ana Teresa Schmid-Braz, Ana Paula de Azambuja, Thais Ferraz-Aguiar, Tamara Borgonovo, Sabine Mai. Cells 2019
5
20


Prognostic factors for multiple myeloma in the era of novel therapies.
Dimitrios C Ziogas, Meletios A Dimopoulos, Efstathios Kastritis. Expert Rev Hematol 2018
11
12


Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax.
R Bajpai, S M Matulis, C Wei, A K Nooka, H E Von Hollen, S Lonial, L H Boise, M Shanmugam. Oncogene 2016
44
12

p53 CRISPR Deletion Affects DNA Structure and Nuclear Architecture.
Aline Rangel-Pozzo, Samuel Booth, Pak Lok Ivan Yu, Madhurendra Singh, Galina Selivanova, Sabine Mai. J Clin Med 2020
2
50

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM).
María-Victoria Mateos, Shaji Kumar, Meletios A Dimopoulos, Verónica González-Calle, Efstathios Kastritis, Roman Hajek, Carlos Fernández De Larrea, Gareth J Morgan, Giampaolo Merlini, Hartmut Goldschmidt,[...]. Blood Cancer J 2020
30
12

Genomic instability in multiple myeloma: mechanisms and therapeutic implications.
Paola Neri, Nizar J Bahlis. Expert Opin Biol Ther 2013
27
12


Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.
M A Shammas, H Koley, R C Bertheau, P Neri, M Fulciniti, P Tassone, S Blotta, A Protopopov, C Mitsiades, R B Batchu,[...]. Leukemia 2008
75
12

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
Niccolo Bolli, Hervé Avet-Loiseau, David C Wedge, Peter Van Loo, Ludmil B Alexandrov, Inigo Martincorena, Kevin J Dawson, Francesco Iorio, Serena Nik-Zainal, Graham R Bignell,[...]. Nat Commun 2014
528
12

The genetic architecture of multiple myeloma.
Gareth J Morgan, Brian A Walker, Faith E Davies. Nat Rev Cancer 2012
550
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.